Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World...

por Ueberall, Michael A, Essner, Ute, Vila Silván, Carlos, Mueller-Schwefe, Gerhard H H
Publicado 2022

Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Mo...

por Ueberall, Michael A, Vila Silván, Carlos, Essner, Ute, Mueller-Schwefe, Gerhard H H
Publicado 2021

Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses

por Oppe, Mark, Ortín-Sulbarán, Daniela, Vila Silván, Carlos, Estévez-Carrillo, Anabel, Ramos-Goñi, Juan M.
Publicado 2021

A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols

por Chisari, Clara Grazia, Guadagno, Joe, Adjamian, Peyman, Vila Silvan, Carlos, Greco, Teresa, Bagul, Makarand, Patti, Francesco
Publicado 2023

A real‐world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described ‘spasticity‐plus syndrome’

por Patti, Francesco, Chisari, Clara Grazia, Fernández, Óscar, Sarroca, Jorge, Ferrer‐Picón, Elena, Hernández Vicente, Francisco, Vila Silván, Carlos
Publicado 2022